Pharmacological modulation of RORα controls fat browning, adaptive thermogenesis, and body weight in mice

Am J Physiol Endocrinol Metab. 2021 Feb 1;320(2):E219-E233. doi: 10.1152/ajpendo.00131.2020. Epub 2020 Nov 30.

Abstract

Beiging is an attractive therapeutic strategy to fight against obesity and its side metabolic complications. The loss of function of the nuclear transcription factor RORα has been related to a lean phenotype with higher thermogenesis in sg/sg mice lacking this protein. Here we show that pharmacological modulation of RORα activity exerts reciprocal and cell-autonomous effect on UCP1 expression ex vivo, in cellulo, and in vivo. The RORα inverse-agonist SR3335 upregulated UCP1 expression in brown and subcutaneous white adipose tissue (scWAT) explants of wild-type (WT) mice, whereas the RORα agonist SR1078 had the opposite effect. We confirmed the reciprocal action of these synthetic RORα ligands on gene expression, mitochondrial mass, and uncoupled oxygen consumption rate in cultured murine and human adipocytes. Time course analysis revealed stepwise variation in gene expression, first of TLE3, an inhibitor of the thermogenic program, followed by a reciprocal effect on PRDM16 and UCP1. Finally, RORα ligands were shown to be useful tools to modulate in vivo UCP1 expression in scWAT with associated changes in this fat depot mass. SR3335 and SR1078 provoked the opposite effects on the WT mice body weight, but without any effect on sg/sg mice. This slimming effect of SR3335 was related to an increased adaptive thermogenesis of the mice, as assessed by the rectal temperature of cold-stressed mice and induction of UCP1 in scWAT, as well as by indirect calorimetry in presence or not of a β3-adrenoceptor agonist. These data confirmed that RORα ligands could be useful tools to modulate thermogenesis and energy homeostasis.NEW & NOTEWORTHY The regulation of adipose tissue browning was not fully deciphered and required further studies explaining how the regulation of this process may be of interest for tackling obesity and related metabolic disorders. Our data confirmed the involvement of the transcription factor RORα in the regulation of nonshivering thermogenesis, and importantly, revealed the possibility to in vivo modulate its activity by synthetic ligands with beneficial consequences on fat mass and body weight of the mice.

Keywords: RORα; browning; in vivo; synthetic ligands; white adipose tissue.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adipocytes / drug effects
  • Adipocytes / physiology
  • Adipose Tissue, Brown / drug effects*
  • Adipose Tissue, Brown / physiology
  • Adipose Tissue, White / drug effects
  • Adipose Tissue, White / physiology
  • Adult
  • Animals
  • Benzamides / pharmacology
  • Body Weight / drug effects*
  • Cell Transdifferentiation / drug effects
  • Cells, Cultured
  • Cold-Shock Response / drug effects
  • Cold-Shock Response / physiology
  • Female
  • Humans
  • Mice
  • Mice, Inbred C57BL
  • Mice, Mutant Strains
  • Nuclear Receptor Subfamily 1, Group F, Member 1 / agonists*
  • Nuclear Receptor Subfamily 1, Group F, Member 1 / physiology
  • Sulfonamides / pharmacology*
  • Thermogenesis / drug effects*
  • Thiazoles / pharmacology
  • Thiophenes / pharmacology*

Substances

  • Benzamides
  • Nuclear Receptor Subfamily 1, Group F, Member 1
  • Rora protein, mouse
  • SR 1078
  • SR 3335
  • SR1001
  • Sulfonamides
  • Thiazoles
  • Thiophenes